Ozempic & GLP-1 Weight Loss Drug Lawsuit Attorneys Home \ New York Personal Injury Lawyer \ New York Ozempic & GLP-1 Weight Loss Drug Lawsuit Attorneys John Richmond, Co-Founder and CEO June 18, 2026 Recent scientific studies and thousands of reported cases have linked popular GLP-1 receptor agonist medicationsoriginally designed for Type 2 diabetes but widely prescribed for weight lossto life-altering side effects
Research indicates that individuals with type 2 diabetes tend to lose less weight with these medications, as much as 4 to 5 kilograms less than non-diabetics
Potency loss can also occur without visible change, so solutions stored beyond the validated shelf life must be discarded regardless of appearance
I think there are many people who are using it as a marketing tool because they want people to think you're not on a full dose of a GLP-1," she says
Our program is tailored to your unique needs and provides a holistic approach to weight management, combining medical expertise, personalized nutrition plans, and ongoing support
Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome